Panel Discussion: Discussing the Current Status of Neuroinflammatory Biomarkers & Existing Obstacles to Overcome in Neuroimmunology
Time: 3:30 pm
day: Day One
Details:
• Outlining the challenges of using fluid and CSF biomarkers to determine efficacy against neuroinflammation from remote sites of action
• Discussing emerging and established imaging tools for neuroinflammation in neurological indications
• Explaining the need for longitudinal samples to assist in biomarker validation and reliability in the clinic
• How does the recent accepted use of NfL as a surrogate endpoint in ALS impact the neuroimmunology field?
